Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Despite progress in identifying molecular pathophysiological processes in schizophrenia, valid biomarkers are lacking for both the disease and treatment response. METHODS: This comprehensive review summarises recent efforts to identify molecular mechanisms on the level of protein and gene expression and epigenetics, including DNA methylation, histone modifications and micro RNA expression. Furthermore, it summarises recent findings of alterations in lipid mediators and highlights inflammatory processes. The potential that this research will identify biomarkers of schizophrenia is discussed. RESULTS: Recent studies have not identified clear biomarkers for schizophrenia. Although several molecular pathways have emerged as potential candidates for future research, a complete understanding of these metabolic pathways is required to reveal better treatment modalities for this disabling condition. CONCLUSIONS: Large longitudinal cohort studies are essential that pair a thorough phenotypic and clinical evaluation for example with gene expression and proteome analysis in blood at multiple time points. This approach might identify biomarkers that allow patients to be stratified according to treatment response and ideally also allow treatment response to be predicted. Improved knowledge of molecular pathways and epigenetic mechanisms, including their potential association with environmental influences, will facilitate the discovery of biomarkers that could ultimately be effective tools in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1094 · Cited by 4,398
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488 · cited 5×
“…found for 2011–2014 and even more in 2015. receptor subunit NR1 (NMDAR1-ABs) in connection with a condition called anti-NMDA receptor encephalitis (Dalmau et al. 2008) has raised hopes that these ABs may potentially explain an “immunological subgroup” of schizophrenia, thereby also serving as…”
BackgroundInfluentialPro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041 · cited 1×
“Omega-3 fatty acids (docosahexaenoic acid, DHA, 22:6n-3, and eicosapentaenoic acid, EPA, 20:5n-3) have recently been shown to form anti-inflammatory/ immuno-resolving signalling lipids that counterbalance the activity of inflammatory signalling lipids (Serhan 2014; Serhan et al. 2015).”
BackgroundTan, M., Luo, H., Lee, S., Jin, F., Yang, J. S., Montellier, E., Buchou, T., Cheng, Z., Rousseaux, S., Rajagopal, N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.008 · Cited by 1,902 · cited 3×
“(2 01 6) and small protein (ubiquitin, SUMO) modification of specific lysine residues, as well as arginine (R) methylation and citrullination, serine (S) phosphorylation, tyrosine (T) hydroxylation and several others (Kouzarides 2007; Taverna et al. 2007; Tan et al. 2011).”
BackgroundMeta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742 · cited 1×
“Increased levels of pro-inflammatory cytokines are the most consistent immunological finding in schizophrenia (Kim et al. 2004; Miller et al. 2011).”
BackgroundCommon variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677 · cited 2×
“Since its first publication in 2009 (Stefansson et al. 2009), the psychiatric genomics consortium (PGC, http://www.”
BackgroundKynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Genome-wide association analysis identifies 13 new risk loci for schizophrenia
Multicenter Genetic Studies of Schizophrenia Consortium, Ripke, S., Psychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2, O'Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., Bergen, S. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2742 · Cited by 1,496
Self-citationMicroglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 2×
“…al. 2012), although it may also be interpreted as a non-inflammatory deregulation of microglia gene expression networks that control microglial functions implicated in synaptic and axonal pruning processes and ultimately fine tune neuronal networks during young adulthood (Prinz and Priller 2014).”
BackgroundImplication of sperm RNAs in transgenerational inheritance of the effects of early trauma in mice
Gapp, K., Jawaid, A., Sarkies, P., Bohacek, J., Pelczar, P., Prados, J., Farinelli, L., Miska, E., & Mansuy, I. M. (2014) · Nature Neuroscience · doi:10.1038/nn.3695 · Cited by 1,306
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269
Recovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227 · cited 1×
“Conversely, some of the chromatinmodifying drugs, such as the histone deacetylase inhibitors (HDACi), profoundly affect brain metabolism and behaviour in the animal model (Fischer et al. 2007; Schroeder et al. 2007; Vecsey et al. 2007; Abel and Zukin 2008; Kurita et al. 2012; Schroeder et al. 2013).”
BackgroundSelf-citationGenetic architectures of psychiatric disorders: the emerging picture and its implications
Sullivan, P. F., Daly, M. J., & O'Donovan, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3240 · Cited by 1,177 · cited 2×
“…common genetic risk variants mainly affect regulatory elements of the genome and thus alter mRNA and microRNA gene expression networks causally implicated in the aetiology of the disease (Sullivan et al. 2012). ncRNA plays a critical role in regulating the timing and rate of protein translation.”
BackgroundTansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
Phospholipase A2 structure/function, mechanism, and signaling
Burke, J. E., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800033-jlr200 · Cited by 933
Insel, T. R., & Cuthbert, B. N. (2015) · Science · doi:10.1126/science.aab2358 · Cited by 840
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium (2015) · Nature Neuroscience · doi:10.1038/nn.3922 · Cited by 755
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease
Lunnon, K., Smith, R., Hannon, E., De Jager, P. L., Srivastava, G., Volta, M., Troakes, C., Al-Sarraj, S., Burrage, J., Macdonald, R., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3782 · Cited by 574
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-7 · Cited by 565
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00128-6 · Cited by 555
Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse
Schroeder, F. A., Lin, C. L., Crusio, W. E., & Akbarian, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.036 · Cited by 541 · cited 1×
“Conversely, some of the chromatinmodifying drugs, such as the histone deacetylase inhibitors (HDACi), profoundly affect brain metabolism and behaviour in the animal model (Fischer et al. 2007; Schroeder et al. 2007; Vecsey et al. 2007; Abel and Zukin 2008; Kurita et al. 2012; Schroeder et al. 2013).”
BackgroundSelf-citationSerhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W., & Chiang, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.006 · Cited by 492
Dempster, E. L., Pidsley, R., Schalkwyk, L. C., Owens, S., Georgiades, A., Kane, F., Kalidindi, S., Picchioni, M., Kravariti, E., Toulopoulou, T., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr416 · Cited by 460 · cited 2×
“However, certain regions of the periphery and CNS may share some common epigenetic characteristics (Dempster et al. 2011; Lunnon et al. 2014; Stenz et al. 2015).”
BackgroundHammer, C., Stepniak, B., Schneider, A., Papiol, S., Tantra, M., Begemann, M., Sirén, A.-L., Pardo, L. A., Sperling, S., Mohd Jofrry, S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.110 · Cited by 342 · cited 10×
“Other common neurotropic infections, including those with members of the herpes virus family, or HLA alleles did not reveal any association (Hammer et al. 2014a).”
BackgroundMethodInfluentialSelf-citationThe impact of environmental factors in severe psychiatric disorders
Schmitt, A., Malchow, B., Hasan, A., & Falkai, P. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00019 · Cited by 322 · cited 4×
“Many genes contribute to this disorder, each with a small effect, and also interact with environmental factors (Schmitt et al. 2014a, 2014b).”
BackgroundInfluentialSelf-citationWalton, E., Hass, J., Liu, J., Roffman, J. L., Bernardoni, F., Roessner, V., Kirsch, M., Schackert, G., Calhoun, V., & Ehrlich, S. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv074 · Cited by 286
Drexhage, R. C., Knijff, E. M., Padmos, R. C., Heul-Nieuwenhuijzen, L. V. D., Beumer, W., Versnel, M. A., & Drexhage, H. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.144 · Cited by 263 · cited 1×
“In addition, higher plasma levels of IL-2 appear to be a promising and specific biomarker for schizophrenia (Drexhage et al. 2010), which may reflect the clinical symptoms as well as cognitive function (Asevedo et al. 2014) particularly since the levels decrease following treatment with…”
BackgroundLosing your nerves? Maybe it's the antibodies
Diamond, B., Huerta, P. T., Mina-Osorio, P., Kowal, C., & Volpe, B. T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2529 · Cited by 247
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Myint, A.-M., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.008 · Cited by 230
Self-citationWillemsen, M. H., Vallès, A., Kirkels, L. A. M. H., Mastebroek, M., Olde Loohuis, N., Kos, A., Wissink-Lindhout, W. M., de Brouwer, A. P. M., Nillesen, W. M., Pfundt, R., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100294 · Cited by 202
Melas, P. A., Rogdaki, M., Ösby, U., Schalling, M., Lavebratt, C., & Ekström, T. J. (2012) · The FASEB Journal · doi:10.1096/fj.11-202069 · Cited by 186
Association of DNA methylation differences with schizophrenia in an Epigenome-Wide association study
Montano, C., Taub, M. A., Jaffe, A., Briem, E., Feinberg, J. I., Trygvadottir, R., Idrizi, A., Runarsson, A., Berndsen, B., Gur, R. C., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0144 · Cited by 180 · cited 1×
“Some of these replicated, differentially methylated positions are located in a top-ranked schizophrenia region identified in genome-wide association studies (GWAS; Montano et al. 2016).”
BackgroundNohesara, S., Ghadirivasfi, M., Mostafavi, S., Eskandari, M.-R., Ahmadkhaniha, H., Thiagalingam, S., & Abdolmaleky, H. M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.06.013 · Cited by 168
Myelination and Oligodendrocyte Functions in Psychiatric Diseases
Nave, K.-A., & Ehrenreich, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.189 · Cited by 157
Self-citationCarrard, A., Salzmann, A., Malafosse, A., & Karege, F. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.018 · Cited by 138
Martins-de-Souza, D., Harris, L. W., Guest, P. C., & Bahn, S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3459 · Cited by 134 · cited 1×
“Other proteins associated with dysfunction of glucose metabolism, energy production, and oxidative stress are aldolase c (ALDOC), lactate dehydrogenase B (LDHB), superoxide dismutase (SOD1) and peroxiredoxins (PRDX 2, 4, 6) (Martins-de-Souza et al. 2011).”
BackgroundSelf-citationTherapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet
Saher, G., Rudolphi, F., Corthals, K., Ruhwedel, T., Schmidt, K.-F., Löwel, S., Dibaj, P., Barrette, B., Möbius, W., & Nave, K.-A. (2012) · Nature Medicine · doi:10.1038/nm.2833 · Cited by 123 · cited 1×
“…analyses for consequences of serum ABs in conditions of BBB breakdown: (1) ApoE KO mice with well-established BBB leakage (Fullerton et al. 2001; Saher et al. 2012), injected intravenously with extracted serum Ig from human NMDAR1-AB carriers, showed alterations in spontaneous open-field…”
BackgroundHalliday, M. R., Pomara, N., Sagare, A. P., Mack, W. J., Frangione, B., & Zlokovic, B. V. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3841 · Cited by 119 · cited 1×
“…seronegative patients (Hammer et al. 2014a); and (3) the interaction of APOE4 carrier status, causing leakage of the BBB that increases with age (Halliday et al. 2013), and NMDAR1-AB seropositivity, was associated with schizoaffective disorder (P¼ .001, odds ratio¼ 6.109) (Hammer et al. 2014b).”
BackgroundInfluentialImpairment of the Blood–Nerve and Blood–Brain Barriers in Apolipoprotein E Knockout Mice
Fullerton, S. M., Shirman, G. A., Strittmatter, W. J., & Matthew, W. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7631 · Cited by 117 · cited 1×
“…and by retrospective analyses for consequences of serum ABs in conditions of BBB breakdown: (1) ApoE KO mice with well-established BBB leakage (Fullerton et al. 2001; Saher et al. 2012), injected intravenously with extracted serum Ig from human NMDAR1-AB carriers, showed alterations in…”
BackgroundIdentification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods
Fonteh, A. N., Harrington, R. J., Huhmer, A. F., Biringer, R. G., Riggins, J. N., & Harrington, M. G. (2006) · Disease Markers · doi:10.1155/2006/202938 · Cited by 113 · cited 2×
“Approaches that use modern mass spectrometry (Fonteh et al. 2006) (which has been successfully applied to other brain diseases; Fonteh et al. 2013, 2014), HPTLC, molecular imaging and magnetic resonance spectroscopy (Bluml et al. 2003; Schmitt et al. 2004; Matsumoto et al. 2011) to define lipid…”
BackgroundMethodSelf-citationAbdolmaleky, H. M., Nohesara, S., Ghadirivasfi, M., Lambert, A. W., Ahmadkhaniha, H., Ozturk, S., Wong, C. K., Shafa, R., Mostafavi, A., & Thiagalingam, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.12.007 · Cited by 102
Nishioka, M., Bundo, M., Koike, S., Takizawa, R., Kakiuchi, C., Araki, T., Kasai, K., & Iwamoto, K. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2012.140 · Cited by 101
Analytical tools and current challenges in the modern era of neuroepigenomics
Maze, I., Shen, L., Zhang, B., Garcia, B. A., Shao, N., Mitchell, A., Sun, H., Akbarian, S., Allis, C. D., & Nestler, E. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3816 · Cited by 100 · cited 1×
“Given the relative ease with which histone PTMs could be studied in nearly all somatic tissues, at high resolution and on a genome-wide scale (Maze et al. 2014), this type of epigenetic information could have excellent potential as a biomarker.”
BackgroundSelf-citationKynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects
Muller, N., Myint, A.-M., & J. Schwarz, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049552 · Cited by 94 · cited 1×
“Excessive kynurenic acid levels have been consistently reported to be associated with schizophrenia, especially in relation to cognitive deficits (for review see Muller et al. 2011).”
BackgroundSelf-citationDe Novo Rates and Selection of Schizophrenia-Associated Copy Number Variants
Rees, E., Moskvina, V., Owen, M. J., O'Donovan, M. C., & Kirov, G. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.011 · Cited by 94
Aberg, K. A., McClay, J. L., Nerella, S., Xie, L. Y., Clark, S. L., Hudson, A. D., Bukszár, J., Adkins, D., Swedish Schizophrenia Consortium, Hultman, C. M., et al. (2012) · Epigenomics · doi:10.2217/epi.12.59 · Cited by 93
Schwarz, E., Guest, P. C., Steiner, J., Bogerts, B., & Bahn, S. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.3 · Cited by 91 · cited 2×
“…Huang et al. 2006, 2007; Martins-de-Souza et al. 2010b; Albertini et al. 2012), blood serum and plasma (Domenici et al. 2010; Levin et al. 2010; Schwarz et al. 2010, 2012a; Jaros et al. 2012), liver (Huang et al. 2007; Prabakaran et al. 2007), fibroblasts (Wang et al. 2010), among others…”
BackgroundSelf-citationAnti-inflammatory treatment in schizophrenia
Müller, N., Myint, A.-M., Krause, D., Weidinger, E., & Schwarz, M. J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.008 · Cited by 89 · cited 1×
“Further evidence for the relevance of an active immune process in schizophrenia comes from clinical trials that demonstrated the therapeutic effect of anti-inflammatory drugs – especially inhibitors of COX-2 (an enzyme that promotes inflammatory processes) (Muller et al. 2002, 2013).”
BackgroundSelf-citationMolecular Profiles of Pyramidal Neurons in the Superior Temporal Cortex in Schizophrenia
Pietersen, C. Y., Mauney, S. A., Kim, S. S., Lim, M. P., Rooney, R. J., Goldstein, J. M., Petryshen, T. L., Seidman, L. J., Shenton, M. E., McCarley, R. W., et al. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2014.882918 · Cited by 87
Numata, S., Ishii, K., Tajima, A., Iga, J.-I., Kinoshita, M., Watanabe, S., Umehara, H., Fuchikami, M., Okada, S., Boku, S., et al. (2015) · Epigenetics · doi:10.1080/15592294.2014.1003743 · Cited by 79
Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications
Szyf, M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.009 · Cited by 76 · cited 1×
“Even experiences related to the familial and social milieu can change the epigenomic landscape and result in neurodevelopmental diseases (Szyf 2015).”
BackgroundMale-Specific Association between Dopamine Receptor D4 Gene Methylation and Schizophrenia
Cheng, J., Wang, Y., Zhou, K., Wang, L., Li, J., Zhuang, Q., Xu, X., Xu, L., Zhang, K., Dai, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089128 · Cited by 60
A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue
van den Oord, E. J. C. G., Clark, S. L., Xie, L. Y., Shabalin, A. A., Dozmorov, M. G., Kumar, G., Swedish Schizophrenia Consortium, Vladimirov, V. I., Magnusson, P. K. E., & Aberg, K. A. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv182 · Cited by 47
Cited by
Smigielski, L., Jagannath, V., Rössler, W., Walitza, S., & Grünblatt, E. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0601-3 · Cited by 168
Self-citationHDAC1 links early life stress to schizophrenia-like phenotypes
Bahari-Javan, S., Varbanov, H., Halder, R., Benito, E., Kaurani, L., Burkhardt, S., Anderson-Schmidt, H., Anghelescu, I., Budde, M., Stilling, R. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613842114 · Cited by 101
Self-citationBDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
Nieto, R. R., Carrasco, A., Corral, S., Castillo, R., Gaspar, P. A., Bustamante, M. L., & Silva, H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.662407 · Cited by 83
“Now Is a Time for Optimism”: The Politics of Personalized Medicine in Mental Health Research
Rüppel, J. (2019) · Science, Technology, & Human Values · doi:10.1177/0162243919845049 · Cited by 12
Metadata
- Authors
- Schmitt, A., Martins-de-Souza, D., Akbarian, S., Cassoli, J. S., Ehrenreich, H., Fischer, A., Fonteh, A., Gattaz, W. F., Gawlik, M., Gerlach, M., Grünblatt, E., Halene, T., Hasan, A., Hashimoto, K., Kim, Y.-K., Kirchner, S.-K., Kornhuber, J., Kraus, T. F. J., Malchow, B., Nascimento, J. M., Rossner, M., Schwarz, M., Steiner, J., Talib, L., Thibaut, F., Riederer, P., Falkai, P., & The Members of the WFSBP Task Force on Biological Markers
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2016-10-26
- Volume
- 18
- Issue
- 5
- Pages
- 330-356
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2539480257
- Cited by
- 38
- References
- 53
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.